NASDAQ:LGST Semper Paratus Acquisition (LGST) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.51▼$5.4050-Day Range$4.51▼$4.7852-Week Range$4.08▼$12.03Volume12,500 shsAverage Volume30,930 shsMarket Capitalization$71.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesOwnershipShort InterestTrendsStock AnalysisHeadlinesOwnershipShort InterestTrends Get Semper Paratus Acquisition alerts: Email Address Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Semper Paratus Acquisition Stock (NASDAQ:LGST)Semper Paratus Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire companies operating in the transportation, supply chain, and logistics industries. Semper Paratus Acquisition Corporation was incorporated in 2021 and is based in New York, New York. Semper Paratus Acquisition Corporation operates as a subsidiary of Ssvk Associates, Llc.Read More Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. LGST Stock News HeadlinesFebruary 14, 2024 | finance.yahoo.comTevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGNFebruary 14, 2024 | globenewswire.comTevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGNJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.February 1, 2024 | msn.comSPAC Semper Paratus shareholders okay merger with Tevogen BioFebruary 1, 2024 | finance.yahoo.comSemper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen BioJanuary 24, 2024 | finance.yahoo.comSemper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on NasdaqJanuary 10, 2024 | investing.comSemper Paratus Acquisition Corp (LGST)January 5, 2024 | finance.yahoo.comTevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business CombinationJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.December 5, 2023 | finance.yahoo.comWith a 56% stake, Semper Paratus Acquisition Corporation (NASDAQ:LGST) insiders have a lot riding on the companySeptember 29, 2023 | finance.yahoo.comSemper Paratus Acquisition Corporation Regains Compliance with Certain Nasdaq Listing RequirementSeptember 14, 2023 | finance.yahoo.comSemper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio IncJune 30, 2023 | msn.comTevogen to go public via merger with SPAC Semper ParatusJune 29, 2023 | reuters.comBiotech firm Tevogen Bio enters $1.2 bln SPAC deal for US listingJune 27, 2023 | morningstar.comSemper Paratus Acquisition Corp Class AApril 17, 2023 | finance.yahoo.comSemper Paratus Acquisition Corporation (LGST)February 24, 2023 | benzinga.comSemper Paratus Acq Stock (NASDAQ:LGSTU), Trade IdeasJanuary 25, 2023 | wsj.comSemper Paratus Acquisition Corp. Cl ASee More Headlines Receive LGST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Semper Paratus Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:LGST CUSIPN/A CIK1860871 Webwww.semperparatusspac.com Phone646-807-8832FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$4.41 million Net MarginsN/A Pretax MarginN/A Return on Equity-21.83% Return on Assets3.10% Debt Debt-to-Equity RatioN/A Current Ratio0.22 Quick Ratio0.22 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.33 per share Price / Cash Flow13.74 Book Value($1.10) per share Price / Book-4.10Miscellaneous Outstanding Shares15,820,000Free Float6,864,000Market Cap$71.35 million OptionableNot Optionable Beta-0.08 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Surendra K. Ajjarapu (Age 53)CEO & Chairman Mr. Francis Knuettel II (Age 58)M.B.A., Chief Financial Officer Key CompetitorsAkiliNASDAQ:AKLIZura BioNASDAQ:ZURAMolecular PartnersNASDAQ:MOLNMonte Rosa TherapeuticsNASDAQ:GLUECaribou BiosciencesNASDAQ:CRBUView All Competitors This page (NASDAQ:LGST) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semper Paratus Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semper Paratus Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.